This inventor holds 1 USPTO granted patent. Top assignee: The University of Manchester. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: David William Ray: Innovator in Selective Glucocorticoid Receptor Agonists
Introduction
David William Ray is a notable inventor based in Belfast, GB. He has made significant contributions to the field of medicine, particularly in the development of selective glucocorticoid receptor agonists. His work focuses on innovative methods for treating various inflammatory conditions and malignancies.
Latest Patents
David William Ray holds a patent for selective glucocorticoid receptor agonists. This invention is directed to a method for treating inflammatory conditions, haematological malignancies, and preventing transplant rejection. The patent involves administering a compound with specific structural formulas, which can be a pharmaceutically acceptable derivative or pro-drug. The compounds described in the patent have potential applications in various therapeutic methods.
Career Highlights
David William Ray is affiliated with the University of Manchester, where he continues to advance his research and innovation in the medical field. His work has garnered attention for its potential impact on treatment methodologies.
Collaborations
He has collaborated with esteemed colleagues such as Stephen Alexander Barr and Michael A McKervey, contributing to the advancement of research in his area of expertise.
Conclusion
David William Ray's contributions to the field of selective glucocorticoid receptor agonists highlight his role as an innovator in medical research. His patent reflects a significant advancement in treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile